ABCG2 and acute myeloid leukemia: Contradictory results were observed with ABCG2 rs2231137, showing a lower OS and lower risk of toxicities ≥ grade three with the GG wild-type genotype in a Caucasian cohort [56], but a higher OS and DFS in a mixed AML/ALL Asian cohort [97] and no influence in a Caucasian cohort [62].